Blog

Applications are open for AIM-HI Women’s Venture Competition and BRACE Award Venture Competition

AIM-HI Accelerator Fund/LinkedIn

Jan 4, 2025, 09:58

Applications are open for AIM-HI Women’s Venture Competition and BRACE Award Venture Competition

AIM-HI Accelerator Fund shared a post on LinkedIn:

“Applications Now Open: AIM-HI Women’s Venture Competition and BRACE Award Venture Competition!

The AIM-HI Accelerator Fund is thrilled to announce that applications are open for two unique opportunities to drive innovation in oncology:

AIM-HI Women’s Venture Competition

This annual competition, launched in partnership with the National Foundation for Cancer Research, is exclusively for women-led oncology companies.

Eligible companies must have at least one senior leadership woman with an equity stake. Since 2020, it has empowered female scientist-entrepreneurs through seed funding, expert coaching, and access to a global network.

BRACE Award Venture Competition

In collaboration with the Asian Fund for Cancer Research, the BRACE Award is open to any oncology company working to make a difference in cancers prevalent in underserved populations.

This program bridges academic innovation with real-world solutions through strategic investment. Both competitions welcome early-stage oncology companies worldwide seeking pre-seed, seed, and Series A investments.

Application Deadline: Saturday, March 15, 2025, at 11:55 PM ET.

Don’t miss this opportunity to propel your oncology startup to the next level.

Learn more and apply today.”

AIM-HI

NFCR shared this post, adding:

“Exciting Opportunities in Oncology Innovation!

At the National Foundation for Cancer Research, we are proud to partner with AIM-HI Accelerator Fund to support programs like the AIM-HI Women’s Venture Competition. These initiatives are empowering entrepreneurs and driving forward breakthroughs in cancer research, with a focus on underserved populations and women-led oncology companies.

If you or someone you know is working on transformative solutions in oncology, don’t miss this chance to apply! Let’s continue building a future where innovation leads to cures.

Learn more and apply here.”